Product Information

GRISEOFULVIN 125 MG/5 ML SUSP is a generic product labeled by Cosette Pharmaceuticals, Inc., priced at $0.3950 per ML under NDC 00713085004. Its NADAC has been published 183 times since Feb 22, 2023.

FDA first approved this application on Oct 8, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

GRISEOFULVIN 125 MG/5 ML SUSP

Griseofulvin
$0.3950per ML

Strength

125 mg/5mL

NDC

00713085004

Classification

Generic

Dosage Form

SUSPENSION

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

GRISEOFULVIN

Approval Type

Generic (ANDA)

FDA Application

ANDA065438

FDA Approved

10/8/2010

TE Code

AB

On Market Since

11/1/2022

Pharmacological Classes

Decreased Mitosis
Microtubule Inhibition
Tubulin Inhibiting Agent

Price Statistics

The NADAC for GRISEOFULVIN 125 MG/5 ML SUSP has been published 183 times since Feb 22, 2023, and over the history we have for it it has declined 3.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3950 per ML
All-time high$1.0444 (Oct 16, 2024)
All-time low$0.3348 (Apr 22, 2026)
52-week high$0.4277
52-week low$0.3348
Median price$0.4202
Average price$0.5144
Largest weekly change+65.1% (Feb 21, 2024)
Weeks tracked183
Tracking sinceFeb 22, 2023

Price History

1W

-2.0%

1M

-2.0%

3M

+10.7%

6M

+7.1%

1Y

-6.0%

3Y

+4.7%

5Y

N/A

All

-3.8%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 36% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 36%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of GRISEOFULVIN 125 MG/5 ML SUSP?

The current National Average Drug Acquisition Cost (NADAC) for GRISEOFULVIN 125 MG/5 ML SUSP, manufactured by Cosette Pharmaceuticals, Inc., is $0.3950 per ML (NDC 00713085004), effective Aug 19, 2026.

How has the price of GRISEOFULVIN 125 MG/5 ML SUSP changed over time?

Over the history we have for it, the NADAC for GRISEOFULVIN 125 MG/5 ML SUSP has declined 3.8%. It has been tracked across 183 weekly CMS publications since Feb 22, 2023.

What are the highest and lowest recorded NADAC prices for GRISEOFULVIN 125 MG/5 ML SUSP?

Since Feb 22, 2023, the NADAC for GRISEOFULVIN 125 MG/5 ML SUSP has ranged from a low of $0.3348 (Apr 22, 2026) to a high of $1.0444 (Oct 16, 2024), with a median of $0.4202 per ML.

Are there cheaper alternatives to GRISEOFULVIN 125 MG/5 ML SUSP?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GRISEOFULVIN 125 MG/5 ML SUSP, is $0.2519 per ML — about 36% below GRISEOFULVIN 125 MG/5 ML SUSP.

Who manufactures GRISEOFULVIN 125 MG/5 ML SUSP?

GRISEOFULVIN 125 MG/5 ML SUSP (NDC 00713085004) is labeled by Cosette Pharmaceuticals, Inc., and CMS classifies it as a generic product.